Lineage Cell Therapeutics, Inc. (LCTX)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 08, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 07:30
Lineage Cell Therapeutics Price to Book Value : 4.526 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 4.526 |
| September 04, 2026 | 4.484 |
| September 03, 2026 | 4.567 |
| September 02, 2026 | 4.608 |
| September 01, 2026 | 4.484 |
| August 31, 2026 | 4.567 |
| August 28, 2026 | 4.608 |
| August 27, 2026 | 4.816 |
| August 26, 2026 | 4.65 |
| August 25, 2026 | 4.692 |
| August 24, 2026 | 4.526 |
| August 21, 2026 | 4.484 |
| August 20, 2026 | 4.484 |
| August 19, 2026 | 4.567 |
| August 18, 2026 | 4.401 |
| August 17, 2026 | 4.401 |
| August 14, 2026 | 4.442 |
| August 13, 2026 | 4.401 |
| August 12, 2026 | 4.567 |
| August 11, 2026 | 4.65 |
| August 10, 2026 | 4.692 |
| August 07, 2026 | 4.567 |
| August 06, 2026 | 4.692 |
| August 05, 2026 | 4.733 |
| August 04, 2026 | 4.65 |
| Date | Value |
|---|---|
| August 03, 2026 | 4.608 |
| July 31, 2026 | 4.484 |
| July 30, 2026 | 4.608 |
| July 29, 2026 | 4.401 |
| July 28, 2026 | 4.442 |
| July 27, 2026 | 4.276 |
| July 24, 2026 | 4.276 |
| July 23, 2026 | 4.442 |
| July 22, 2026 | 4.608 |
| July 21, 2026 | 4.733 |
| July 20, 2026 | 4.567 |
| July 17, 2026 | 4.816 |
| July 16, 2026 | 4.858 |
| July 15, 2026 | 5.065 |
| July 14, 2026 | 5.065 |
| July 13, 2026 | 5.024 |
| July 10, 2026 | 5.314 |
| July 09, 2026 | 5.356 |
| July 08, 2026 | 5.563 |
| July 07, 2026 | 5.480 |
| July 06, 2026 | 5.522 |
| July 02, 2026 | 5.605 |
| July 01, 2026 | 5.397 |
| June 30, 2026 | 5.439 |
| June 29, 2026 | 6.247 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.19 |
| Anika Therapeutics, Inc. | 2.051 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.715 |
Price to Book Value Related Metrics
| PS Ratio | 20.72 |
| PEG Ratio | -6.353 |
| Price | 1.09 |
| Earnings Yield | -16.91% |
| Market Cap | 275.67M |
| PEGY Ratio | -6.353 |